Cornish Metals Releases Unaudited Financial Statements and Management's Discussion and Analysis for the Six Months Ended 30 June 2025 GlobeNewswire August 14, 2025 VANCOUVER, British Columbia, Aug. 14, 2025 (GLOBE NEWSWIRE) — Cornish Metals Inc. (TSX-V/AIM: CUSN) (“Cornish Metals” or the “Company”), a mineral exploration and development company focused on advancing its wholly owned and […]

NEW YORK, NY / ACCESS Newswire / August 14, 2025 / An unexpected layoff, a surprise medical expense or a family emergency that drains your savings could happen to anyone. You might suddenly find yourself a few months behind on rent with a potential eviction notice to come. Options are available to help you get

Medulla Communications Pvt. Ltd., one of the world's most awarded healthcare advertising agencies, has announced its expansion into Singapore, establishing a strategic hub to serve the Asia-Pacific region. Known for its expertise in solving healthcare challenges over 15 years, Medulla is looking to create a new super-specialist category as the first digital healthcare advertising agency

GENEVAD, SE / ACCESS Newswire / August 14, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced the publication of its 2025 half-year report and provided a corporate update. "Relief continued to make steady

Bioretec LtdCompany announcement14 August 2025 at 8.00 am EEST This company announcement is a summary of Bioretec Ltd's half-year report for January-June 2025. The complete half-year report with tables is attached to this release as a pdf file and available at the company's web pages at https://investors.bioretec.com/en/reports_and_presentations. The half-year report is unaudited. April-June 2025 in

Regulation 37(a) of the Securities Regulations (Periodic and Immediate Reports), 1970 Max Stock Limited (TASE: MAXO) (the “Company”) today declared a cash dividend of ILS 0.2865976 per share (ILS 40 million in total), as follows: On August 13, 2025, the Company's board of directors approved a dividend of ILS 0.2865976 per share (ILS 40 million

(SWX:BSLN.SW),(Boerse Stuttgart – Freiverkehr:BSLN),(Boerse Berlin – Freiverkehr:BSLN),(Boerse Frankfurt – Freiverkehr:BSLN),(Boerse Muenchen – Freiverkehr:BSLN), Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, August 14, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that it has entered

Basilea announces in-licensing of a novel clinical phase 3-ready oral antibiotic GlobeNewswire August 14, 2025 Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, August 14, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that it

NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) — Sculpt By Science introduces a groundbreaking health program designed to help CEOs, entrepreneurs, and business leaders optimize their well-being, leading to enhanced professional success. Sculpt By Science Introduces Life-Changing Health Program for High-Performing Business Leaders Sculpt By Science, the leading health and fitness brand founded by Dr.

Sculpt By Science Unveils Exclusive Program to Empower CEOs and Entrepreneurs with Peak Performance GlobeNewswire August 14, 2025 NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) — Sculpt By Science introduces a groundbreaking health program designed to help CEOs, entrepreneurs, and business leaders optimize their well-being, leading to enhanced professional success. Sculpt By Science Introduces Life-Changing